News
17 May 2012
Travers Smith acts on placing of shares in Reckitt Benckiser
Corporate partner Andrew Gillen and US partner Charles Casassa, assisted by US senior associate Dan McNamee, advised JAB Holdings B.V. on the placing of 36,000,000 shares in Reckitt Benckiser Group plc with the gross proceeds amounting to approximately £1.2bn
more
Corporate partner Andrew Gillen and US partner Charles Casassa, assisted by US senior associate Dan McNamee, advised JAB Holdings B.V. on the placing of 36,000,000 shares in Reckitt Benckiser Group plc with the gross proceeds amounting to approximately £1.2bn
more
11 May 2012
Travers Smith advises Milestone Capital Partners on its sale of Cadum
A Travers Smith team led by corporate partner, David Patient, has advised Milestone Capital Partners, the Anglo-French private equity firm, on its sale of Cadum to L´Oréal, the world´s largest beauty group, for an undisclosed sum.
more
A Travers Smith team led by corporate partner, David Patient, has advised Milestone Capital Partners, the Anglo-French private equity firm, on its sale of Cadum to L´Oréal, the world´s largest beauty group, for an undisclosed sum.
more
10 May 2012
Travers Smith is pleased to announce the appointment of Anthony Foster and Caroline Edwards as Co-Heads of Graduate Recruitment
Anthony and Caroline replace Tom Purton who has been head of graduate recruitment for 8 years and who will continue as part of the graduate recruitment team.
more
Anthony and Caroline replace Tom Purton who has been head of graduate recruitment for 8 years and who will continue as part of the graduate recruitment team.
more
08 May 2012
Travers Smith acts on Dechra Pharmaceuticals Rights Issue
Corporate partner Richard Spedding is advising Investec Bank plc on the £60m rights issue by Dechra Pharmaceuticals plc. Investec is acting as financial adviser, sole broker and underwriter to Dechra.
more
Corporate partner Richard Spedding is advising Investec Bank plc on the £60m rights issue by Dechra Pharmaceuticals plc. Investec is acting as financial adviser, sole broker and underwriter to Dechra.
more
30 April 2012
Travers Smith acts on US$104m placing and open offer by Raven Russia
Travers Smith corporate partner Richard Spedding is leading a team advising Singer Capital Markets as sponsor, joint financial adviser and broker in connection with a proposed US$215m acquisition by Raven Russia Limited, and a US$104m placing and open offer of preference shares to part-finance the acquisition.
more
Travers Smith corporate partner Richard Spedding is leading a team advising Singer Capital Markets as sponsor, joint financial adviser and broker in connection with a proposed US$215m acquisition by Raven Russia Limited, and a US$104m placing and open offer of preference shares to part-finance the acquisition.
more